.Neurocrine Biosciences has attained its own hoped-for profile page in a stage 2 schizophrenia trial...
.Vaderis Rehabs' goal to cultivate the very first medicine striven particularly at a specific uncomm...
.Navigator Medicines has furnished on its own along with $100 million in series A funds as the youth...
.China's Duplicity Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, seeking an unr...
.Four months after Mandarin gene modifying provider YolTech Therapies took its own cholesterol disea...
.Indivior is actually grabbing a little particle allosteric modulator tailored to address drug use p...
.Molecular Partners has pinpointed "suboptimal direct exposure" to its own tetra-specific T-cell eng...
.While the biotech expenditure scene in Europe has reduced relatively adhering to a COVID-19 financi...
.After raising $213 million in 2023-- among the year's biggest exclusive biotech rounds-- Volume Bio...
.Invite to this week's Chutes & Ladders, our roundup of substantial management hirings, firings a...